exRNAdisease

Entry Detail

---



General Information

Database ID: exR0354866 RNA Name: hsa-miR-663a RNA Type: miRNA Chromosome: chr20 Starnd: - Coordinate: Start Site(bp): 26208243 End Site(bp): 26208264 External Links: hsa-miR-663a

Disease Information

Disease Name: Glioblastoma Multiforme Disease Category: Cancers MeSH ID: D005909 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell

Expression Detail

GEO ID: GSE93850 Description: Serum miRNAs in Patients with Glioblastoma Multiforme Experimental Design: Cancer vs Control Case Disease Type: Glioblastoma Multiforme Case Disease SubType: NA Case Sample: Glioblastoma Multiforme Control Sample: Healthy Number of Case: 22 Number of Control: 8 Number of Samples: 30

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand COL6A2 chr21 46098112 46132848 + KLC2 chr11 66257294 66267860 + REXO1 chr19 1815248 1848483 - MIDN chr19 1248553 1259140 + STK35 chr20 2101827 2177038 + MIGA2 chr9 129036621 129072082 + SRPRA chr11 126262938 126269144 - KDM2A chr11 67119263 67258082 + JUNB chr19 12791486 12793315 + GNB1 chr1 1785285 1891117 - SYVN1 chr11 65121780 65134533 - SCN1B chr19 35030470 35040449 + SMAD3 chr15 67063763 67195169 + HIF1AN chr10 100529072 100559998 + TNRC6A chr16 24610209 24827632 + ARHGAP1 chr11 46677080 46700619 - ARL8A chr1 202133404 202144743 - PPDPF chr20 63520765 63522206 + KMT5A chr12 123383773 123409353 + RTL8A chrX 135050932 135052196 - SOX12 chr20 325595 330224 + CYB5R3 chr22 42617840 42649392 - PRR12 chr19 49591182 49626439 + CAPN15 chr16 527712 554636 + DMWD chr19 45782947 45792845 - BOC chr3 113211003 113287459 + FAM83H chr8 143723933 143738234 - CLSTN1 chr1 9728926 9823984 - CALR chr19 12938578 12944489 + CMIP chr16 81445170 81711762 + miRNA targets: NA circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC008738.7 chr19 33207129 33207639 + AC020928.2 chr19 36773712 36775908 - AC069281.2 chr7 100572232 100578700 - AC234582.1 chr1 155195004 155205495 + AL137127.1 chr1 19072110 19075511 - AL355075.4 chr14 20343048 20343685 - AL356488.2 chr1 109100193 109100619 + GAS5 chr1 173858559 173868882 - MIR663AHG chr20 26167817 26251546 - NEAT1 chr11 65422774 65445540 + NORAD chr20 36045618 36051018 - SNHG25 chr17 64145970 64146476 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE93850 Sample Source: Blood Source Fraction: Serum Platform: GPL22948 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1032 Sample treatment protocol: NA RNA Extract protocol: Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) RNA library preparation protocol: 0.3ug of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 ul at 16°C overnight.

Reference

PMID: 28931080 Title: Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma Author: Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY,Wu SX Journal: PLoS One. 2017 Sep 20;12(9):e0184969. Description: we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM.